DK0780390T3 - Krystalmodifikation af CDCH, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende denne - Google Patents

Krystalmodifikation af CDCH, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende denne

Info

Publication number
DK0780390T3
DK0780390T3 DK96119134T DK96119134T DK0780390T3 DK 0780390 T3 DK0780390 T3 DK 0780390T3 DK 96119134 T DK96119134 T DK 96119134T DK 96119134 T DK96119134 T DK 96119134T DK 0780390 T3 DK0780390 T3 DK 0780390T3
Authority
DK
Denmark
Prior art keywords
cdch
preparation
pharmaceutical compositions
compositions containing
crystal modification
Prior art date
Application number
DK96119134T
Other languages
Danish (da)
English (en)
Inventor
Patrick Dr Bosche
Alfons Dr Grunenberg
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7779831&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0780390(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DK0780390T3 publication Critical patent/DK0780390T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK96119134T 1995-12-12 1996-11-29 Krystalmodifikation af CDCH, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende denne DK0780390T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19546249A DE19546249A1 (de) 1995-12-12 1995-12-12 Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen

Publications (1)

Publication Number Publication Date
DK0780390T3 true DK0780390T3 (da) 2002-11-11

Family

ID=7779831

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96119134T DK0780390T3 (da) 1995-12-12 1996-11-29 Krystalmodifikation af CDCH, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende denne

Country Status (42)

Country Link
US (1) US5849752A (enExample)
EP (1) EP0780390B1 (enExample)
JP (1) JP4104687B2 (enExample)
KR (1) KR100525146B1 (enExample)
CN (1) CN1061348C (enExample)
AR (1) AR005009A1 (enExample)
AT (1) ATE221531T1 (enExample)
AU (1) AU708006B2 (enExample)
BG (1) BG62258B1 (enExample)
BR (1) BR9605968A (enExample)
CA (1) CA2192418C (enExample)
CO (1) CO4480105A1 (enExample)
CU (1) CU22774A3 (enExample)
CZ (1) CZ288657B6 (enExample)
DE (2) DE19546249A1 (enExample)
DK (1) DK0780390T3 (enExample)
EE (1) EE03474B1 (enExample)
ES (1) ES2179910T3 (enExample)
HR (1) HRP960558B1 (enExample)
HU (1) HU226521B1 (enExample)
ID (1) ID22625A (enExample)
IL (1) IL119795A (enExample)
IN (1) IN185805B (enExample)
MA (1) MA24342A1 (enExample)
MY (1) MY117492A (enExample)
NL (1) NL300109I1 (enExample)
NO (1) NO306725B1 (enExample)
NZ (1) NZ299905A (enExample)
PL (1) PL184885B1 (enExample)
PT (1) PT780390E (enExample)
RO (1) RO119782B1 (enExample)
RU (1) RU2162468C2 (enExample)
SA (1) SA96170492B1 (enExample)
SG (1) SG47201A1 (enExample)
SI (1) SI0780390T1 (enExample)
SK (1) SK282805B6 (enExample)
SV (1) SV1996000109A (enExample)
TR (1) TR199600970A2 (enExample)
TW (1) TW411340B (enExample)
UA (1) UA35638C2 (enExample)
YU (1) YU49485B (enExample)
ZA (1) ZA9610405B (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU226583B1 (hu) * 1997-09-25 2009-04-28 Bayer Ag Moxifloxacint tartalmazó szabályozott hatóanyag-leadású gyógyászati készítmények
DE19751948A1 (de) * 1997-11-24 1999-05-27 Bayer Ag Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US6509327B1 (en) 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
KR100650489B1 (ko) * 1998-11-10 2006-11-28 바이엘 헬스케어 아게 목시플록사신 제약 제제
DE19854357A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854356A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908449A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure
WO2004039804A1 (en) * 2002-10-31 2004-05-13 Ranbaxy Laboratories Limited Amorphous moxifloxacin hydrochloride
EP1615645B2 (en) † 2003-04-09 2013-08-21 Dr. Reddy's Laboratories Ltd. A crystalline form iii of anhydrous moxifloxacin hydrochloride and a process for the preparation thereof
WO2005012285A1 (en) * 2003-08-05 2005-02-10 Matrix Laboratories Ltd An improved process for the preparation of moxifloxacin hydrochloride
ITMI20032259A1 (it) 2003-11-20 2005-05-21 Chemi Spa Nuovo polimorfo dell'acido 1-ciclopropil-7-(s,s-2,8-diazabciclo-4.3.0-non-8-il)-6-fluoro-1,4-diidro-8-metossi-4-oxo-chinolin carbossilico cloridrato e metodi per la sua preparazione
DE602004018370D1 (de) * 2003-11-20 2009-01-22 Chemi Spa Polymorphe von 1-cyclopropyl-7-(äs,sü - 2,8-diazadicyclo ä4.3.0ü non-8-yl) -6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäurehydrochlorid und verfahren zu deren herstellung
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
DE102004015981A1 (de) * 2004-04-01 2005-10-20 Bayer Healthcare Ag Neue kirstalline Form von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE102004063347A1 (de) * 2004-12-23 2006-07-13 Stada Arzneimittel Ag Gebrauchsfertige Gemcitabinlösungen und Gemcitabinlösungskonzentrate
WO2007033515A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation orale contenant de la moxifloxacine et son procédé de préparation
GB0612422D0 (en) * 2006-06-23 2006-08-02 Generics Uk Ltd Novel hydrate form
AU2007264030B2 (en) 2006-06-27 2012-04-05 Sandoz Ag New method for salt preparation
ES2303768B1 (es) * 2006-09-08 2009-06-05 Quimica Sintetica, S.A. Nueva forma cristalina de moxifloxacino clorhidrato.
KR20150048920A (ko) 2006-11-13 2015-05-07 씨아이피엘에이 엘티디. 목시플록사신 염산염의 합성방법
EP1992626A1 (en) * 2007-05-10 2008-11-19 Sandoz AG Process for the preparation of moxifloxacin hydrochloride
EP2083010A1 (en) * 2008-01-08 2009-07-29 Chemo Ibérica, S.A. Polymorphic Forms of Moxifloxacin hydrochloride and processes for preparation thereof
EP2154137A1 (en) 2008-08-04 2010-02-17 Chemo Ibérica, S.A. Crystalline form of moxifloxacin base
TR201106844T2 (tr) 2008-10-09 2012-02-21 Abd� �Brah�M �La� Sanay� Ve T�Caret Anon�M ��Rket�@ Moksi̇floksasi̇n yaş granülasyonunda organi̇k solventleri̇n kullanimi.
EP2342204A1 (en) * 2008-11-06 2011-07-13 Hetero Research Foundation Novel polymorph of moxifloxacin hydrochloride
EP2364141B2 (de) 2008-12-08 2017-08-02 ratiopharm GmbH Kompaktiertes moxifloxacin
NZ610978A (en) 2009-05-15 2014-11-28 Redx Pharma Ltd Redox drug derivatives
WO2011121596A2 (en) * 2010-04-01 2011-10-06 Neuland Laboratories Ltd. Crystal modification of moxifloxacin hydrochloride
BRPI1106900A2 (pt) 2011-12-26 2013-11-05 Ems Sa Composição farmacêutica sólida compreendendo antibótico da familia das quinolonas e processo de sua obtenção
FR2992218B1 (fr) 2012-06-22 2015-01-23 Rivopharm Sa Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation
CN102924449B (zh) * 2012-10-30 2015-08-12 重庆福安药业集团庆余堂制药有限公司 盐酸莫西沙星h晶型及其制备方法和药物组合物
WO2014087292A1 (en) 2012-12-04 2014-06-12 Mankind Research Centre An improved process for the preparation of moxifloxacin hydrochloride
RU2561037C2 (ru) * 2013-02-07 2015-08-20 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Антибактериальная фармацевтическая композиция и способ ее получения
CA2904387C (en) 2013-03-15 2021-12-07 Melinta Therapeutics, Inc. Methods of treating infections in overweight and obese patients using antibiotics

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601567A1 (de) * 1986-01-21 1987-07-23 Bayer Ag 7-(azabicycloalkyl)-chinoloncarbonsaeure- und -naphthyridon-carbonsaeure-derivate
FI871419L (fi) * 1986-03-31 1987-10-01 Sankyo Co Kinolin-3-karboxylsyraderivat, deras framstaellning och anvaendning.
AU609974B2 (en) * 1988-05-18 1991-05-09 Warner-Lambert Company Improved process for the preparation of 5-amino-7- (substituted amino)-quinoline-3-carboxylic acids
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
RO108347B1 (ro) * 1989-10-30 1994-04-28 Bellon Labor Sa Roger DERIVATI DE BENZO-(b)-NAFTIRIDIN-1,8 SI PROCEDEU DE PREPARARE A ACESTORA
TW209865B (enExample) 1992-01-10 1993-07-21 Bayer Ag
WO1993015070A1 (fr) * 1992-01-31 1993-08-05 Chugai Seiyaku Kabushiki Kaisha Cristal d'hydrate de derive d'acide quinolonecarboxylique
DE4234078A1 (de) * 1992-10-09 1994-04-14 Bayer Ag Chinoloncarbonsäuren
JP3268098B2 (ja) * 1992-12-25 2002-03-25 第一製薬株式会社 二環性環状アミン誘導体
ZA946853B (en) * 1993-09-10 1995-04-24 Daiichi Seiyaku Co Crystals of antimicrobial compound.
EP0676199B1 (en) * 1994-04-07 1998-09-02 Pfizer Inc. Use of trovafloxacin or derivatives thereof for the manufacture of a medicament for the treatment of H. pylori infections

Also Published As

Publication number Publication date
SK159196A3 (en) 1997-10-08
CU22774A3 (es) 2002-07-24
HRP960558A2 (en) 1998-02-28
SG47201A1 (en) 1998-03-20
PL184885B1 (pl) 2003-01-31
KR970042550A (ko) 1997-07-24
CZ288657B6 (cs) 2001-08-15
CO4480105A1 (es) 1997-07-09
KR100525146B1 (ko) 2006-01-27
NO306725B1 (no) 1999-12-13
ZA9610405B (en) 1997-06-23
EE9600201A (et) 1997-06-16
BR9605968A (pt) 1998-08-18
EE03474B1 (et) 2001-08-15
SA96170492B1 (ar) 2006-05-23
ID22625A (id) 1999-12-02
SV1996000109A (es) 1997-10-23
HU9603428D0 (en) 1997-01-28
NZ299905A (en) 1998-09-24
CA2192418C (en) 2001-06-12
CA2192418A1 (en) 1997-06-13
YU49485B (sh) 2006-08-17
PL317415A1 (en) 1997-06-23
US5849752A (en) 1998-12-15
IL119795A (en) 1998-12-27
UA35638C2 (uk) 2001-04-16
EP0780390B1 (de) 2002-07-31
JP4104687B2 (ja) 2008-06-18
IL119795A0 (en) 1997-03-18
PT780390E (pt) 2002-11-29
CZ364696A3 (en) 1997-07-16
HUP9603428A3 (en) 1997-10-28
NO965298D0 (no) 1996-12-11
YU65096A (sh) 1998-12-23
ATE221531T1 (de) 2002-08-15
MA24342A1 (fr) 1998-07-01
DE59609501D1 (de) 2002-09-05
SK282805B6 (sk) 2002-12-03
BG101043A (en) 1998-04-30
RO119782B1 (ro) 2005-03-30
TW411340B (en) 2000-11-11
MX9606325A (es) 1997-10-31
AU7421696A (en) 1997-06-19
ES2179910T3 (es) 2003-02-01
CN1160052A (zh) 1997-09-24
IN185805B (enExample) 2001-05-05
TR199600970A2 (tr) 1997-06-21
HUP9603428A2 (en) 1997-08-28
EP0780390A1 (de) 1997-06-25
JPH09169757A (ja) 1997-06-30
SI0780390T1 (en) 2002-10-31
RU2162468C2 (ru) 2001-01-27
BG62258B1 (bg) 1999-06-30
CN1061348C (zh) 2001-01-31
NL300109I1 (nl) 2003-02-03
NO965298L (no) 1997-06-13
DE19546249A1 (de) 1997-06-19
AR005009A1 (es) 1999-04-07
MY117492A (en) 2004-07-31
HRP960558B1 (en) 2002-04-30
AU708006B2 (en) 1999-07-29
HU226521B1 (en) 2009-03-30

Similar Documents

Publication Publication Date Title
DK0780390T3 (da) Krystalmodifikation af CDCH, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende denne
DK1156049T3 (da) Substituerede heterocykliske forbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DK0861089T3 (da) Metoder og sammensætninger til indgivelse af monomere proteiner
DK0817780T3 (da) Taxoider, fremstilling af disse forbindelser og farmaceutiske præparater indeholdende disse forbindelser
DK0610487T3 (da) Nye aminosyrederivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende disse forbindelser
NO964700D0 (no) Nye aminosyrederivater, fremgangsmåte til deres fremstilling og farmasöytiske blandinger som inneholder disse forbindelser
DK0496386T3 (da) Katalysatorbærer samt sammensætning og fremgangsmåde til fremstilling af denne
DK0612741T3 (da) Cykliske derivater, lægemidler indeholdende disse forbindelser og fremgangsmåde til deres fremstilling
DK0812195T3 (da) Farmaceutisk sammensætning til piperidinoalkanolforbindelser
NO975987D0 (no) 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater
DK0941103T3 (da) Farmaceutisk præparat til behandling af diabetes
DK0670367T3 (da) Flydendegørende alkalisk alfa-amylase, fremgangsmåde til fremstilling af denne og detergentsammensætning indeholdende denne
DK0885204T3 (da) Nye arylglycinamidderivater, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende disse forbindelser
NO981150L (no) Konsentrert, flytende vaskemiddelblanding og fremgangsmÕte for fremstilling av denne
DK0839138T3 (da) Fremgangsmåde til fremstilling af N-substituerede 3-hydroxypyrazoler
DK0719775T3 (da) Substituerede derivater af 4-phenylthiazol, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger, der inde
DK0735042T3 (da) Maltitolsammensætning og fremgangsmåde til fremstilling deraf
DK0805797T3 (da) Fremgangsmåde til fremstilling af N-aryl- og N-hetarylhydroxylaminer
DK102990D0 (da) Thieno-triazolodiazepinderivater, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse
DK0583338T3 (da) Fremgangsmåde til syntese af peptider, hidtil ukendte aminosyrederivater anvendt i denne fremgangsmåde og fremgangsmåder til deres fremstilling
DK1031565T3 (da) Hidtil ukendte krystaller af depsipeptidderivat og fremgangsmåde til fremstilling heraf
DK187989A (da) Substituerede propanaminer, fremgangsmaade til fremstilling heraf og laegemidler indeholdende saadanne forbindelser
DK0727417T3 (da) Substituerede benzensulfonylurinstoffer og -thiourinstoffer, fremgangsmåde til deres fremstilling og anvendelse af farmaceutiske præparater på grundlag af disse forbindelser samt lægemidler, der indeholder dem
FI944751A7 (fi) Heteroaryylipiperidiinejä, menetelmä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia
DK0998470T3 (da) Fremgangsmåde til fremstilling af aminderivater af alkyloxyfuranon, forbindelser fremstillet ved denne fremgangsmåde og anvendelse af disse forbindelser